Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Surface antigens of Mycobacterium tuberculosis" refers to the diverse group of proteins, polysaccharides, and glycolipids exposed on the cell envelope, capsule, and secreted from the bacterium Mycobacterium tuberculosis (Mtb)[1][2][3][5]. These antigens include proteins like OmpA, PE-PGRS, PTRP, ESAT-6, and PstS1; polysaccharides such as α-glucan and arabinomannan (AM); and glycolipids such as lipoarabinomannan (LAM) and trehalose dimycolate[2][3][4][5][6]. They play crucial roles in Mtb virulence, immune evasion, and facilitating uptake by host cells. Antibodies targeting these antigens can promote bacterial clearance via opsonization and antibody-dependent cellular phagocytosis, and some surface antigens serve as promising vaccine candidates and diagnostic markers. However, the full repertoire of protective surface antigens remains incompletely defined, and the broad categorization as "surface antigens" is inaccurate as a specific molecular therapeutic target[1][2][5]. For drug or vaccine targeting, precise identification at the molecular level (e.g., ESAT-6, OmpA, PstS1, LAM) is essential.
Antibody opsonization (promoting phagocytosis via Fc receptor-mediated uptake); Inhibition of antigen presentation (e.g., ESAT-6 complex sequestering β2M and inhibiting MHC-I expression); Direct inhibition of bacterial growth; Modulation of immune cell activation (via antibody- and antigen-mediated signaling)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Surface antigen of Mycobacterium tuberculosis.